Announce Date | 12/31/1969 |
EPS Normalized Actual | $ In Line |
EPS GAAP Actual | $ In Line |
Revenue Actual | $1.8289B |
Revenue Surprise | Beat by $1828.9M |
Announce Date | 09/30/2025 (Pre-Market) |
EPS Normalized Estimate | $0.13667 |
EPS GAAP Estimate | $0.13667 |
Revenue Estimate | $2.0735275B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2029 | 0 | INF | 0 | 0 | 0 |
Dec 2028 | 0.34 | 0.03 | 0.33414 | 0.35052 | 1 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ1 2025 (Mar 2025) | -0.12 | -0.12 | 1.8289B | 100% | -205.98M |
FQ4 2024 (Dec 2024) | -0.072 | -0.072 | 1.99211B | 100% | -139.15M |
FQ3 2024 (Sep 2024) | 0.23 | 0.1125 | 0.025749B | 100% | -2385.77M |
FQ3 2012 (Sep 2012) | 0.0038 | 0.0038 | 0.310854B | 100% | 310.85M |
FQ4 2012 (Dec 2012) | -0.0011 | -0.0011 | 0.276882B | 100% | 276.88M |
FQ1 2013 (Mar 2013) | -0.0042 | -0.0042 | 0.254729B | 100% | 254.73M |
FQ2 2013 (Jun 2013) | 0.0015 | 0.0015 | 0.27598B | 100% | 275.98M |
FQ3 2013 (Sep 2013) | 0.0016 | 0.0016 | 0.422749B | 26.47% | 422.75M |
FQ4 Announce Date
09/30/2025 (Pre-Market)
Consensus EPS Estimates
0.13667
Consensus Revenue Estimates
2.0735275B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | -0.02 | -- | -0.02045392 | -0.01941516 | 1 |
FQ3 2027 (Sep 2027) | 0.16 | -- | 0.15532 | 0.16363 | 1 |
FQ2 2027 (Jun 2027) | 0.1 | -- | 0.09707582 | 0.10227 | 1 |
FQ1 2027 (Mar 2027) | -0.22 | -- | -0.22499 | -0.21357 | 1 |
FQ3 2026 (Sep 2026) | 0.16 | -- | 0.15532 | 0.16363 | 1 |
FQ2 2026 (Jun 2026) | 0.115 | -- | 0.11164 | 0.11761 | 1 |
FQ1 2026 (Mar 2026) | -0.17 | 29.41 | -0.17386 | -0.16503 | 1 |
FQ3 2025 (Sep 2025) | 0.13667 | -68.29 | 0.13267 | 0.13977 | 1 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 1.86B | -- | 1.82B | 1.9B | 3 |
FQ3 2027 (Sep 2027) | 2.04B | -- | 1.99B | 2.07B | 2 |
FQ2 2027 (Jun 2027) | 1.96B | -- | 1.92B | 2B | 2 |
FQ1 2027 (Mar 2027) | 1.72B | -- | 1.68B | 1.75B | 3 |
FQ3 2026 (Sep 2026) | 2.06B | -- | 2.02B | 2.1B | 2 |
FQ2 2026 (Jun 2026) | 2.01B | -- | 1.96B | 2.04B | 2 |
FQ1 2026 (Mar 2026) | 1.79B | -2.36 | 1.75B | 1.82B | 3 |
FQ3 2025 (Sep 2025) | 2.07B | 98.76 | 2.03B | 2.11B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
4
EPS # of Misses
4
EPS # of in-lines
0
Revenue # of Beats
5
Revenue # of Misses
3
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | 0 | -0.12 | -0.12 | 100% |
FQ4 2024 (Dec 2024) | 0 | -0.072 | -0.072 | 100% |
FQ3 2024 (Sep 2024) | 0.1175 | 0.23 | 0.1125 | 48.91% |
FQ3 2012 (Sep 2012) | 0.0038 | 0.0038 | 100% | |
FQ4 2012 (Dec 2012) | -0.0011 | -0.0011 | 100% | |
FQ1 2013 (Mar 2013) | -0.0042 | -0.0042 | 100% | |
FQ2 2013 (Jun 2013) | 0.0015 | 0.0015 | 100% | |
FQ3 2013 (Sep 2013) | 0.0016 | 0.0016 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | $2.03B | $1.83B | $-205.98M | -11.26% |
FQ4 2024 (Dec 2024) | $2.13B | $1.99B | $-139.15M | -6.99% |
FQ3 2024 (Sep 2024) | $2.41B | $0.03B | $-2385.77M | -9265.48% |
FQ3 2012 (Sep 2012) | $0B | $0.31B | $310.85M | 100% |
FQ4 2012 (Dec 2012) | $0B | $0.28B | $276.88M | 100% |
FQ1 2013 (Mar 2013) | $0B | $0.25B | $254.73M | 100% |
FQ2 2013 (Jun 2013) | $0B | $0.28B | $275.98M | 100% |
FQ3 2013 (Sep 2013) | $0B | $0.42B | $422.75M | 100% |